Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01339559 · ClinicalTrials.gov registry record · Phase 3

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

A Phase 3 study of Epilepsy, sponsored by UCB Biosciences.

Completed
Registry status
Phase 3
Development phase
767
Enrollment target
20
Study locations

NCT01339559 is a Phase 3 study of Epilepsy that has completed, run by UCB Biosciences. The registered enrollment target is 767 participants, below the 948-participant average among 160 other Epilepsy trials with a reported enrollment target (19% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01339559, a Phase 3 study of Epilepsy, has completed, sponsored by UCB Biosciences.

COMPLETED
Registry status
Phase 3
Development phase
767 participants
Enrollment target
20
Study locations

Study Summary

This is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).

Conditions Studied

Epilepsy

Interventions

  • DRUG Brivaracetam

Study Locations (20)

Arizona

  • 001 - Phoenix
  • 013 - Phoenix
  • 006 - Tucson

Florida

  • 071 - Miami
  • 027 - Orlando
  • 064 - Port Charlotte

Illinois

  • 029 - Chicago
  • 005 - Peoria
  • 017 - Winfield

Georgia

  • 023 - Atlanta
  • 048 - Rome

Iowa

  • 020 - Ames
  • 069 - Iowa City

Maryland

  • 008 - Bethesda
  • 068 - Waldorf

Arkansas

  • 775 - Little Rock

California

  • 025 - San Francisco

Trial Details

FieldValue
Enrollment Target 767 participants
Start Date 2011-05-11
Est. Completion 2019-04-18
Phase Phase 3

Sponsor

UCB Biosciences

39 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01339559

The ClinicalTrials.gov registry entry for NCT01339559 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 767 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 948-participant average among 160 other Epilepsy trials with a reported enrollment target (19% lower). The listed sponsor is UCB Biosciences, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Brivaracetam is the first listed.

NCT01339559 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Arizona, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT01339559 about?

NCT01339559 is a clinical study titled "Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy". This is a Phase 3, open label, long term follow-up (LTFU), multicenter, noncomparative, and single arm study of brivaracetam (BRV).

What is the current status of trial NCT01339559?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 767 participants. The study started on 2011-05-11. Estimated completion is 2019-04-18.

What conditions does trial NCT01339559 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT01339559?

The interventions under investigation include: Brivaracetam (DRUG).

Who is sponsoring clinical trial NCT01339559?

This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01339559 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.